Open for bids Tender Germany ICB TOT Ref. 152653877

Conclusion of Non-Exclusive Discount Agreements Tender - 152653877

Tender notice from Germany, published on 18 Nov 2026.

Executive Summary

Title/Summary: Tender for non-exclusive discount agreements for the active ingredient Ustekinumab, issued by GWQ ServicePlus AG in Düsseldorf, Germany. The contract is set to commence on January 1, 2027.

Scope Of Work: The tender involves establishing non-exclusive discount agreements for Ustekinumab in accordance with § 130a Abs. 8 SGB V. GWQ ServicePlus AG will conduct a formal procurement process for these agreements, allowing all interested pharmaceutical companies to join under the same conditions. The transition agreement will be open to all market participants until exclusive contracts begin. The initial reporting can be realized by December 1, 2026, for a contract start on January 1, 2027.

Qualification Criterion: Bidders must submit a signed contract in duplicate or with a qualified electronic signature, a list of the relevant PZN, and self-declarations as specified in the tender documents. Additional documentation, such as proof of pharmaceutical approval from the AMIce database, may be requested. The tender is open to all pharmaceutical companies, ensuring non-discriminatory access.

Key facts

Summary
Conclusion of Non-Exclusive Discount Agreements in Accordance with Section 130 a Paragraph 8 Sgb V with the Active Ingredient Ustekinumab from January 1, 2027
TOT Ref. No.
152653877
Document Ref. No.
Login to see
Country
Germany
Notice type
Tender
Competition
ICB
Publication date
18 Nov 2026
Bid deadline
10 Aug 2028
EMD
Refer Document
Tender value
Refer Document
Purchaser ownership
Public
Financier
Self Financed

CPV classification

Purchaser details

Purchaser contact is for registered users

Login to see details

Tender details

Tender details are for registered users

Login to see details

Documents

Tender Notice
Login to view

Similar tenders

Germany Public Procurement Intelligence

Frequently asked questions

The last date to submit a bid for Conclusion of Non-Exclusive Discount Agreements in Accordance with Section 130 a Paragraph 8 Sgb V with the Active Ingredient Ustekinumab from January 1, 2027 is 10 Aug 2028. Submit before this date to be considered.

This tender has been issued by GWQ SERVICEPLUS AG in Germany.

The tender value is not disclosed; please refer to the tender document. EMD / bid security details are provided in the tender document.

This tender is Self Financed

The tender is classified under the following CPV code(s): 33600000 - Pharmaceutical products.

The tender notice and related documents are listed in the Documents section above. Select a document to view or download it. Please log in or register to access the documents. If you cannot find additional documents in the Documents section, please log in to your account and Send Document Request from your account section.

The TendersOnTime reference is 152653877. The purchaser document reference is available after login.

See the Similar Tenders section on this page or browse other tenders from Germany.

This tender falls under Materials and Products, Technology and Equipment in Germany. Suppliers in these sectors can track similar Germany tenders using CPV-based alerts.